Payment Expert Summit returns to SBC Summit Rio at a pivotal moment for both Brazil’s payments ecosystem and gaming sector.
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), the first and only subcutaneously (SC) ...
Capital One Financial stands to gain as digital payments grow, rates ease and consumer spending stays strong, extending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback